Treatment of chronic hepatitis C in elderly patients

Necessities of Interferon Therapy in Elderly Patients with Chronic Hepatitis C

(2009) Kenji Ikeda et al.   AMERICAN JOURNAL OF MEDICINE

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

(2009) Barbara Rehermann   JOURNAL OF CLINICAL INVESTIGATION

Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C

(2009) Avidan U. Neumann et al.   JOURNAL OF HEPATOLOGY

617 EFFICACY AND SAFETY OF PEGYLATED INTERFERON- ALPHA PLUS RIBAVIRIN COMBINATION THERAPY IN OLD AGE CHRONIC HEPATITIS C PATIENTS

(2009) C.-Y. Dai et al.   JOURNAL OF HEPATOLOGY

Peginterferon alfa-2a (40kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients

(2009) K. R. Reddy et al.   JOURNAL OF VIRAL HEPATITIS

Antiviral resistance and specifically targeted therapy for HCV (STAT-C)

(2009) A. J. V. Thompson et al.   JOURNAL OF VIRAL HEPATITIS

The history of the “natural history” of hepatitis C (1968-2009)

(2009) Leonard B. Seeff   LIVER INTERNATIONAL

Senescence of Activated Stellate Cells Limits Liver Fibrosis

(2008) Valery Krizhanovsky et al.   CELL

Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads

(2008) Hitomi Sezaki et al.   DIGESTIVE DISEASES AND SCIENCES

Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection

(2008) Matthew Hoare et al.   HEPATOLOGY

13 POTENTIAL NEGATIVE IMPACT OF AGING ON HEPATOCARCINOGENESIS AFTER ANTI-VIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C AND BENEFIT OF VIRAL ERADICATION BY PEG-INTERFRON/RIBAVIRIN TREATMENT

(2008) Y. Asahina et al.   JOURNAL OF HEPATOLOGY